Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult Patients With KCNJ11 Permanent Diabetes
Open Access
- 11 February 2014
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 37 (3), e55-e56
- https://doi.org/10.2337/dc13-2280
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: A case reportDiabetes Research and Clinical Practice, 2013
- Update in neonatal diabetesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2010
- Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating MutationsDiabetes Care, 2007
- Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 MutationsNew England Journal of Medicine, 2006